tirzepatide dry eye Diabetes: May Lower Risk of Diabetic Retinopathy Zepbound and Dry Eyes: A

In October 2024, the Medicines and Healthcare products Regulatory Agency (MHRA) issued a reminder to healthcare professionals regarding the prescription-only status of GLP-1s, retiring the importance of adverse reporting and the need to remain vigilant to potential misuse 6

At 2mg/mL, it equals 0.25mL

However, few data exist that demonstrate different treatment outcomes in phenotypically defined patients, with the exception of cystoscopic treatment of Hunner lesions (see Management of Interstitial Cystitis/Bladder Pain Syndrome )

First-in-Human trials follow a cautious and progressive dose-escalation approach designed to support continuous safety evaluation throughout the study